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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A381elongated. CFU-F assays carried out under 3% oxygen conditions dis-
played greater numbers of colonies formed over those grown in 21%
oxygen (69% vs. 53%). Osteogenic and adipogenic differentiation of SF-
MSCs under 3% oxygen was reduced over cells differentiated in 21%
oxygen. Chondrogenic differentiation under low oxygen tension of 3%
oxygen resulted in elevated levels of GAG/DNA over cells differentiated
in ambient oxygen (mean values of 3.7 mg/mg vs. 1.9 mg/mg).
Conclusions: These studies demonstrate that human SF-MSC pop-
ulations can be expanded under serum-free conditions without loss of
lineage diversity, and that this proliferation can be increased by serially
propagating the cells under 3% oxygen tension to enhance chondro-
genic potential. The propensity of these cells for chondrogenic differ-
entiation increased when the oxygen tension was lowered from 21% to
3% oxygen, in contrast to the osteogenic and adipogenic lineages. Such
low oxygen conditions may better reﬂect the endogenous oxygen levels
in avascular cartilage. Thus, these ﬁndings will contribute to the opti-
mization of bioprocesses aimed at scaling-up and differentiating SF-
MSCs for use in regenerative therapies for articular cartilage.
Figure 1. Representative photomicrographs of a CFU-F assay of cells grown
under 21% (A) and 3% (B) oxygen, to determine their colony forming
ability.
Figure 2. Chondrogenic pellets differentiated under 21% (A,B) and 3% (C,D)
oxygen. Scale bars represent 100 mm.
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Purpose: Cartilage damage is a major problem in osteoarthritis.
Application of bone marrow-derived mesenchymal stem cells (BMSCs)
to heal damaged cartilage is promising due to their capacity to differ-
entiate into chondrocytes. However, clinical results from BMSC-based
therapies are suboptimal because chondrogenic differentiation is vari-
able, and the functional properties of repair tissue differ from native
cartilage. To tackle this problem, we need to better understand the
molecular events during chondrogenic differentiation of BMSCs.Previously, we showed that the SMAD2/3 pathway is crucial for chon-
drogenic differentiation of BMSCs. Transforming Growth Factor-b
(TGFb) is well known to activate this pathway by initiating phosphor-
ylation of SMAD2/3 proteins (pSMAD2/3). Besides TGFb, both Activin A
and Nodal are known to induce pSMAD2/3. Therefore, we investigated
whether Activin A and/or Nodal, like TGFb, can initiate chondrogenesis
in BMSCs.
Methods: Human fetal BMSCs (purchased from ScienCell) were pellet-
cultured in serum-free chondrogenic medium without ligands or with
either 10 ng/mL TGFb1; 10 or 100 ng/mL Activin A; 10 or 100 ng/mL
Nodal for 1 or 7 days. At day 1, proteins were isolated from stimulated
and unstimulated pellets for western blot analysis of pSMAD2/3. To
observe whether cartilage matrix was formed after 7 days, BMSC pellets
were harvested for histological evaluation of proteoglycan deposition
and mRNA expression analysis of aggrecan, collagen type II and
pSMAD2/3-responsive gene plasminogen activator inhibitor-1 (PAI1).
Relative mRNA levels were measured using Q-RT-PCR and corrected for
ribosomal protein S27a expression.
Results: Activin A, TGFb1, and Nodal dose-dependently induced
SMAD2/3 phosphorylation compared to unstimulated BMSC pellets.
pSMAD2/3 levels were highest upon TGFb1 stimulation and lowest
upon Nodal. This was also reﬂected by PAI1 gene expression. However,
despite all three ligands were proven to be bioactive, only TGFb1 ini-
tiated chondrogenic differentiation of fetal BMSC pellets, as shown by
increased ACAN and COL2 expression. Moreover, chondrogenesis was
conﬁrmed in TGFb1-stimulated pellets by positive proteoglycan stain-
ing, whereas pellets stimulated with Activin A or Nodal were devoid of
cartilage-like tissue.
Conclusions: Previously, SMAD2/3 phosphorylation was found crucial
for initiating chondrogenesis in BMSCs. In the present study we dem-
onstrate that TGFb initiated chondrogenic differentiation of BMSCs,
whereas Activin A and Nodal did not. Our data suggest that amongst the
pSMAD2/3-inducing ligands (Activin A, TGFb, or Nodal), only TGFb
initiates chondrogenic differentiation of BMSCs. To improve cartilage
formation by BMSCs, all molecular events induced by TGFb in mesen-
chymal stem cells needs to be further explored.
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CHONDROGENIC PROGENITOR CELLS ARE KEY PLAYERS IN THE
REGENERATION OF CARTILAGE TISSUE
N. Miosge. Univ. Goettingen, Goettingen, Germany
Purpose: The regeneration of diseased hyaline cartilage continues to be
a great challenge, mainly because degeneration overtaxes the tissue's
self-renewal capacity.
Methods: Up to date, more than 600 samples of adult osteoarthritic
cartilage, without signs of rheumatoid involvement, were obtained
from the knee joints of patients (ages: 65 - 75 years) suffering from late-
stage osteoarthritis (OA) after total knee replacement. Recently, we also
includedmeniscus specimens from late OA (n¼ 150), as well as samples
from rheumatoid arthritis (n ¼ 40) in our investigation of progenitor
cells in situ. Histology, immunohistochemistry and staging was carried
out as described. Standard explant cultures were performed. A tran-
scriptome analyses and proteome analysis further characterized the
progenitor cell populations. We performed dilution cloning and lenti-
viral transfection of hTERTof the cells. Quantitative real-time RT-PCR, as
well as Western blotting was applied after overexpression and RNA
silencing experiments for various chondrogenic mediators, for example,
sox9, smad2 or HMGB2. Cell stimulation experiments involved TGFß3,
PDGF or BMP6.
Results: Recently, we demonstrated that repair tissue from human
articular cartilage during the late stages of osteoarthritis harbors a
unique progenitor cell population, termed chondrogenic progenitor
cells (CPCs). These exhibit stem cell characteristics such as clonoge-
nicity, multipotency, and migratory activity. The isolated CPCs, which
exhibit a high chondrogenic potential, were shown to populate diseased
tissue ex vivo. Moreover, down-regulation of the osteogenic tran-
scription factor Runx2 enhanced the expression of the chondrogenic
transcription factor Sox9. This, in turn, increased the matrix synthesis
potential of the CPCs without altering their migratory capacity (Koelling
et al., 2009, Cell Stem Cell). Furthermore, we analyzed sex-speciﬁc
differences in the regenerative potential of CPCs and the involvement of
sex hormones as well as of primary cilia. Migration of CPCs is inﬂuenced
via PDFG receptors. Here, we describe similar progenitor cell pop-
ulations in cartilage tissue of patients with rheumatoid arthritis, as well
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meniscus. Also osteoarthritic cartilage of DDR-1-deﬁcient mice harbors
a progenitor cell population.
Conclusions: Taken together, we propose that speciﬁc progenitor cell
populations found in situ are responsible for tissue regeneration in a
wide variety of cartilage tissues in humans andwill be of importance for
cell biological therapeutic interventions in osteoarthritis.
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Purpose:We are studying the cell based- and pharmaceutical-
approaches for cartilage repair, combined with surgical bone marrow
stimulation technique to supply the cells contributing to wound heal.
Bone marrow tissue has heterogeneous cell-populations, including
hematopoietic stem cells, and we prefer to enhance the cells with as
better chondrogenic ability as possible in order to promote cartilage
repair process. It has been known that direct intra-articular injection of
basic ﬁbroblast growth factor (bFGF) promotes articular cartilage repair
of osteochondral defect in animal model, however bFGF also has an
unfavorable action for clinical application, osteophyte formation. In
vitro studies have shown that the supplementation of bFGF for human
bone marrow derived mesenchymal stem cells (hBMSCs) during
expansion phase maintains the chondrogenic potential as well as
enhance their proliferation. However, the population of hBMSCs sup-
plemented with bFGF has not been investigated enough yet. This study
aimed to analyze some characters, size and MSC markers, of the pop-
ulation of hBMSCs with bFGF.
Methods: Bone marrow aspirates were obtained from healthy donors
by routine iliac crest aspiration with their agreement and seeded to
culture ﬂasks, mixed with 2-fold volume of growth medium containing
15% lot adjusted FBS, supplemented with or without 10ng/ml bFGF
(PeproTech, NJ, USA ). Non-adherent cells were removed at 3days and
culture medium was changed every 3 days. At 11 to 14 days, P0 end,
hBMSCs were passed to P1 and cultured with 5% FBS containing growth
medium, keeping the condition of bFGF. The P1 cells were prepared for
immunocytochemistry and for the conﬁrmation of the chondrogenic
ability. The size of the cells was measured with the automated Coulter
cell counter at the end of P0 and P1. For immunocytochemistry, the cells
at day4 on P1 stage were ﬁxed with 4% PFA, and then Endoglin on cell
surface were stained. The cells harvested at P1 end were used to per-
form pellet culture for 21 days. The histology sections of the pellets
were stained with Safranin-O/Fast green, and the glycosaminoglycan
(GAG) contents were measured and normalized with DNA (GAG/DNA),
to evaluate their chondrogenic ability. The data of two groups, with or
without bFGF on P0 and P1, were compared using unpaired t-test.
Statistical tests were considered signiﬁcant at the level of P < 0.05.
Results: The size of the bFGF supplemented-hBMSCs was signiﬁcantly
smaller than hBMSCs without bFGF at P0 and P1, both. Most of the cells
regardless with bFGF supplementation were expressed Endoglin,
however bFGF supplemented-hBMSCs seemed to express Endoglin
more. The pellets from the cells expanded with bFGF were bigger and
histology of them showed Safranin-O stained more and contained more
GAG/DNA than another as previously reported.
Conclusions: The population of hBMSCs supplemented with bFGF has
some distinct characters, smaller size and probably more expression of
Endoglin than hBMSCs without bFGF. Endoglin has been reported as an
accessory receptor for transforming growth factor-b (TGF-b) and might
modulate the downstream signal molecules, such as smad-1/5/8, of
hBMSCs. Gene expression level of Endoglin needs to be measured, and
other MSC markers as well are going to be investigated. The cells
involving in the cartilage repair would be characterized more, and if we
could target and enhance this kind of the cells with any other agent
than bFGF during cartilage repair process, better cartilage repair might
be acquired.Synovial Tissue Biology & Biochemistry
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PROGRESSION OF OSTEOPHYTE FORMATION IN EARLY
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Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However, if and
how this synovial activation contributes to the irreversible joint path-
ology that characterizes OA, is not known. In the present study we used
microarray analysis of unique synovial tissue samples of early OA
patients and of experimental OA, to identify common pathways that
may determine progression of cartilage damage and osteophyte for-
mation in this disease.
Methods: From 25 patients with knee OA that entered the CHECK
Cohort study Cohort Hip and Cohort Knee) and 6 controls, synovial
biopsies were collected at baseline. CHECK is a prospective 10-year
follow-up study on patients with early osteoarthritis-related com-
plaints initiated by the Dutch Arthritis Association. At baseline and
follow-up, highly standardized radiographs were taken, and analyzed
using the KIDA (Knee Image Digital Analysis) system. Progression was
determined based on change of joint space width (JSW) and osteophyte
size in radiographs, as analyzed using the KIDA (Knee Image Digital
Analysis) system. Synovial samples from baseline were studied using
histology and affymetrix U133-plus-2.0 chips, which were analyzed
using Partek Genomics Suite software and Functional Annotation
Clustering (FAC) was done using DAVID.
Results:Upon histological examination at baseline, we found that lining
thickness and synovitis were enhanced in the CHECK biopsies com-
pared to control synovia. Gene expression proﬁles of control synovia
were compared to our unique set of CHECK synovia. FAC analysis
indicated enrichment of several biological processes and signaling
pathways, including regulation of macrophage differentiation, innate
immune responses, cell migration, TGFb-, BMP- and wnt-signaling. This
indicates activation of the synovium in the CHECK patients compared to
controls. To determine whether any of the regulated genes and path-
ways were predictive for progression of joint damage between baseline
and t¼5, we identiﬁed 13 patients that were marked progressors and
non-progressors, based on JSW (respectively n¼13 vs n¼8) or osteo-
phyte size (respectively n¼10 vs n¼11) at these time points. At baseline,
neither minimum JSW nor osteophyte size differed between the groups.
Approximately 200 genes were expressed more than 2-fold higher in
synovium of osteophyte-progressors, and approximately 100 genes in
the group of JSW-progressors. Among the genes that were differentially
expressed by osteophyte progressors were MMP1, 2, 3, 9 and -14,
whereas in JSW-progressors onlyMMP1was differentially expressed. In
the group of JSW-progressors, macrophage markers like CD14, S100A8,
S100A9, MHC class II genes, and Cxcr2 were positively associated with
progression. This indicates that expression of these factors may predict,
or even be involved in, progression of cartilage damage in OA patients.
The osteophyte-progressors also showed an increase of most of these
markers, but to a far lesser extent. Using FAC we identiﬁed inﬂamma-
tory response, macrophage differentiation, blood vessel formation,
ossiﬁcation and cell migration to be enriched in patients that show
progression of joint space narrowing 5 years later. Blood vessel for-
mation, wound healing, ossiﬁcation and cell proliferation were
enriched in osteophyte-progressors. Histologically, the JSW-progressors
showed a higher thickness of the lining layer and a higher cellularity in
the sublining compared to non-progressors, and compared to osteo-
phyte progressors. Both JSW-progressors and osteophyte-progressors
showed increased vascularisation compared to non-progressors.
Conclusions: These data suggest an active role for the synovium in OA
pathology, and identiﬁes pathways that are likely to be involved. We
found evidence for e difference in underlying processes in the synovium
regarding progression of cartilage damage and progression of osteo-
phyte formation. Fromhistology and the expression data, it appears that
